European Progress On Biosimilars Is Just The Beginning

But A Comprehensive European Biosimilars Strategy Is Needed To Realize Potential

 
• By Dave Wallace
  
Isabell Remus speaking at Medicines for Europe's 20th annual biosimilar medicines conference
Isabell Remus addresses Medicines for Europe’s 20th annual biosimilar medicines conference • Source: Medicines for Europe

More from Biosimilars

More from Conferences